Anti-Human ERBB3 & CD221 Recombinant Antibody
-
产品编号
YR1370
-
别名
科研级 Istiratumab ( 艾司妥单抗 ), Anti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Istiratumab ( 艾司妥单抗 ), Anti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab |
| Catalog Number | YR1370 |
| Molecular Name | Istiratumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa -[scFv]2 |
| Formulation | PBS, pH7.5 |
| Background | Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer. |
| CAS Number | 1509928-04-4 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | ERBB3 & CD221[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
